# FDA Inspection 1089646 - Biomat USA Inc - March 28, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/19e2cbb0-96d8-4e0e-98bb-932edf577ff2
Source feed: FDA_Inspections

> FDA Inspection 1089646 for Biomat USA Inc on March 28, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1089646
- Company Name: Biomat USA Inc
- Inspection Date: 2019-03-28
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1052043 - 2018-03-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/98ca94cf-23f1-451c-ad93-f878f10820e9)
- [FDA Inspection 985194 - 2016-07-19](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/6d499b6e-6050-47a2-9910-7190338c3df1)
- [FDA Inspection 898357 - 2014-09-28](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/871bd362-5095-4b57-812d-423b1dc83f04)
- [FDA Inspection 720538 - 2011-04-21](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/79af57fc-a731-4743-afdf-50d8de981dbf)

Company: https://www.keypedia.com/companies/biomat-usa-inc/66144318-3044-4c19-845a-8f670b2ba31a

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d